ETFs That Hold MoonLake Immunotherapeutics (MLTX)
Like MoonLake Immunotherapeutics but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.
Reverse lookup across 72 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.
Common questions
How many ETFs hold MoonLake Immunotherapeutics (MLTX)?
MoonLake Immunotherapeutics (MLTX) is held by 12 US-listed ETFs, in each fund's latest reported holdings.
Which ETF holds the most MoonLake Immunotherapeutics?
Of the US-listed ETFs in our fund data, T. Rowe Price Health Care ETF (TMED) holds MoonLake Immunotherapeutics at the largest portfolio weight, in each fund's latest reported holdings.
What ETFs hold MoonLake Immunotherapeutics?
By portfolio weight, the US-listed ETFs that hold the most MoonLake Immunotherapeutics are TMED, BBC, OPTZ, KBFR and GWX, among others, in each fund's latest reported holdings.

